Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multi-Phase In Silico Discovery of Potential SARS-CoV-2 RNA-Dependent RNA Polymerase Inhibitors among 3009 Clinical and FDA-Approved Related Drugs
Eslam B. Elkaeed, Hazem Elkady, Amany Belal, et al.
Processes (2022) Vol. 10, Iss. 3, pp. 530-530
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Design and synthesis of thiazolidine-2,4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: in-vitro anticancer evaluation and in-silico studies
Mohammed S. Taghour, Hazem Elkady, Wagdy M. Eldehna, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1903-1917
Open Access | Times Cited: 81
Multi-Step In Silico Discovery of Natural Drugs against COVID-19 Targeting Main Protease
Eslam B. Elkaeed, Fadia S. Youssef, Ibrahim H. Eissa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 6912-6912
Open Access | Times Cited: 54
The Assessment of Anticancer and VEGFR-2 Inhibitory Activities of a New 1H-Indole Derivative: In Silico and In Vitro Approaches
Eslam B. Elkaeed, Reda G. Yousef, Hazem Elkady, et al.
Processes (2022) Vol. 10, Iss. 7, pp. 1391-1391
Open Access | Times Cited: 45
A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease
Eslam B. Elkaeed, Ibrahim H. Eissa, Hazem Elkady, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8407-8407
Open Access | Times Cited: 44
Modified Benzoxazole-Based VEGFR-2 Inhibitors and Apoptosis Inducers: Design, Synthesis, and Anti-Proliferative Evaluation
Alaa Elwan, Abdallah E. Abdallah, Hazem A. Mahdy, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 5047-5047
Open Access | Times Cited: 43
Design, synthesis, anti-proliferative evaluation, docking, and MD simulations studies of new thiazolidine-2,4-diones targeting VEGFR-2 and apoptosis pathway
Mohammed S. Taghour, Hazem Elkady, Wagdy M. Eldehna, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0272362-e0272362
Open Access | Times Cited: 40
Discovery of new quinoline and isatine derivatives as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative, docking and MD simulation studies
Mohammed S. Taghour, Hazem Elkady, Wagdy M. Eldehna, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 21, pp. 11535-11550
Open Access | Times Cited: 29
Computer-aided drug discovery of natural antiviral metabolites as potential SARS-CoV-2 helicase inhibitors
Eslam B. Elkaeed, Ibrahim H. Eissa, Abdulrahman M. Saleh, et al.
Journal of Chemical Research (2024) Vol. 48, Iss. 1
Open Access | Times Cited: 8
Integrated in silico and in vitro exploration of the anti-VEGFR-2 activities of a semisynthetic xanthine alkaloid inhibiting breast cancer
Eslam B. Elkaeed, Hazem Elkady, Ahmed M. Khattab, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0316146-e0316146
Open Access
Benzoxazole derivatives as new VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, in silico studies, and antiproliferative evaluation
Mohammed S. Taghour, Hazem A. Mahdy, Maher H. Gomaa, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2063-2077
Open Access | Times Cited: 34
New Anticancer Theobromine Derivative Targeting EGFRWT and EGFRT790M: Design, Semi-Synthesis, In Silico, and In Vitro Anticancer Studies
Eslam B. Elkaeed, Reda G. Yousef, Hazem Elkady, et al.
Molecules (2022) Vol. 27, Iss. 18, pp. 5859-5859
Open Access | Times Cited: 31
In silico and in vitro evaluation of the anti-virulence potential of patuletin, a natural methoxy flavone, against Pseudomonas aeruginosa
Ahmed M. Metwaly, Moustafa M. Saleh, Aisha A. Alsfouk, et al.
PeerJ (2024) Vol. 12, pp. e16826-e16826
Open Access | Times Cited: 5
In silico, in vitro VEGFR-2 inhibition, and anticancer activity of a 3-(hydrazonomethyl)naphthalene-2-ol derivative
Eslam B. Elkaeed, Reda G. Yousef, Hazem Elkady, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 16, pp. 7986-8001
Closed Access | Times Cited: 22
Anticancer derivative of the natural alkaloid, theobromine, inhibiting EGFR protein: Computer-aided drug discovery approach
Ibrahim H. Eissa, Reda G. Yousef, Eslam B. Elkaeed, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0282586-e0282586
Open Access | Times Cited: 12
Multistaged In Silico Discovery of the Best SARS-CoV-2 Main Protease Inhibitors amongst 3009 Clinical and FDA-Approved Compounds
Ibrahim H. Eissa, Abdulrahman M. Saleh, Sara T. Al‐Rashood, et al.
Journal of Chemistry (2024) Vol. 2024, pp. 1-19
Open Access | Times Cited: 4
The Computational Preventive Potential of the Rare Flavonoid, Patuletin, Isolated from Tagetes patula, against SARS-CoV-2
Ahmed M. Metwaly, Eslam B. Elkaeed, Bshra A. Alsfouk, et al.
Plants (2022) Vol. 11, Iss. 14, pp. 1886-1886
Open Access | Times Cited: 19
Computer-assisted drug discovery of potential natural inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase through a multi-phase in silico approach
Eslam B. Elkaeed, Bshra A. Alsfouk, Tuqa H. Ibrahim, et al.
Antiviral Therapy (2023) Vol. 28, Iss. 5
Open Access | Times Cited: 11
Synthesis, biological evaluation and computer-aided discovery of new thiazolidine-2,4-dione derivatives as potential antitumor VEGFR-2 inhibitors
Hazem Elkady, Osama A. El-Dardir, Alaa Elwan, et al.
RSC Advances (2023) Vol. 13, Iss. 40, pp. 27801-27827
Open Access | Times Cited: 11
Comprehensive structural and functional analysis of Patuletin as a potent inhibitor of SARS-CoV-2 targeting the RNA-dependent RNA polymerases
Ahmed M. Metwaly, Esmail M. El‐Fakharany, Aisha A. Alsfouk, et al.
Journal of Molecular Structure (2024) Vol. 1311, pp. 138424-138424
Closed Access | Times Cited: 3
Structure-Based Virtual Screening, Docking, ADMET, Molecular Dynamics, and MM-PBSA Calculations for the Discovery of Potential Natural SARS-CoV-2 Helicase Inhibitors from the Traditional Chinese Medicine
Ahmed M. Metwaly, Alaa Elwan, Abdul-Aziz M.M. El-Attar, et al.
Journal of Chemistry (2022) Vol. 2022, pp. 1-23
Open Access | Times Cited: 17
Modified pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as EGFRWT and EGFRT790M inhibitors: Design, synthesis, and anti-cancer evaluation
Eman S. Nossier, Rania A. Alasfoury, Mohamed Hagras, et al.
Journal of Molecular Structure (2022) Vol. 1270, pp. 133971-133971
Closed Access | Times Cited: 16
Discovery of Potential SARS-CoV-2 Papain-like Protease Natural Inhibitors Employing a Multi-Phase In Silico Approach
Eslam B. Elkaeed, Ahmed M. Metwaly, Mohamed S. Alesawy, et al.
Life (2022) Vol. 12, Iss. 9, pp. 1407-1407
Open Access | Times Cited: 16
Discovery of Some Heterocyclic Molecules as Bone Morphogenetic Protein 2 (BMP-2)-Inducible Kinase Inhibitors: Virtual Screening, ADME Properties, and Molecular Docking Simulations
Amany Belal, Hazem Elkady, Ahmed A. Al‐Karmalawy, et al.
Molecules (2022) Vol. 27, Iss. 17, pp. 5571-5571
Open Access | Times Cited: 15
Computer-Assisted Drug Discovery of Potential African Anti-SARS-CoV-2 Natural Products Targeting the Helicase Protein
Ahmed M. Metwaly, Mohamed S. Alesawy, Bshra A. Alsfouk, et al.
Natural Product Communications (2024) Vol. 19, Iss. 4
Open Access | Times Cited: 2
Repurposing FDA-Approved Drugs as Potential Inhibitors of SARS-CoV-2 PLpro: A Comprehensive Computational Study
Ahmed M. Metwaly, Eslam B. Elkaeed, Aisha A. Alsfouk, et al.
Journal of Computational Biophysics and Chemistry (2024) Vol. 23, Iss. 09, pp. 1209-1231
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top